Imprivata (NYSE: IMPR) and AppFolio (NASDAQ:APPF) are both enterprise software companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Earnings and Valuation

This table compares Imprivata and AppFolio’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Imprivata N/A N/A N/A ($0.95) N/A
AppFolio $105.59 million 14.71 -$8.28 million $0.03 1,527.18

Imprivata has higher revenue, but lower earnings than AppFolio. Imprivata is trading at a lower price-to-earnings ratio than AppFolio, indicating that it is currently the more affordable of the two stocks.


This table compares Imprivata and AppFolio’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Imprivata -17.22% -58.85% -22.17%
AppFolio 0.84% 1.46% 1.12%

Analyst Ratings

This is a summary of current recommendations for Imprivata and AppFolio, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Imprivata 0 0 0 0 N/A
AppFolio 0 3 2 0 2.40

AppFolio has a consensus target price of $36.50, suggesting a potential downside of 20.31%.

Institutional & Insider Ownership

59.3% of Imprivata shares are owned by institutional investors. Comparatively, 21.3% of AppFolio shares are owned by institutional investors. 40.2% of Imprivata shares are owned by company insiders. Comparatively, 44.8% of AppFolio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.


AppFolio beats Imprivata on 7 of the 8 factors compared between the two stocks.

About Imprivata

Imprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.

About AppFolio

AppFolio, Inc. is a provider of industry-specific, cloud-based software solutions for small and medium-sized businesses (SMBs) in the property management and legal industries. The Company’s mobile-optimized software solutions enable its customers to work at any time and from anywhere across multiple devices. Its property management software provides small and medium-sized property managers with an end-to-end solution to their business needs. The Company’s legal software provides solo practitioners and small law firms with a streamlined practice and case management solution, allowing them to manage their practices and case load. It also offers Value+ services, such as its professionally designed Websites and electronic payment services. The Company’s property manager customers include third-party managers and owner-operators, managing single- and multi-family residences, commercial property and student housing, as well as mixed real estate portfolios.

Receive News & Ratings for Imprivata Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imprivata Inc and related companies with's FREE daily email newsletter.